Results 101 to 110 of about 13,529 (168)

Fenofibrate mitigates microglial activation by reprogramming lipid metabolism and inhibiting ferroptosis. [PDF]

Mol Cell Biochem
Taskesen A, Hacioglu C, Tuncer S, Kilic G, Tuncer C.   +4 more
europepmc   +1 more source

Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug-Polymer Interactions to in vivo Performance. [PDF]

Drug Des Devel Ther
Ridwan S, Pratiwi R, Hildayani SZ, Budiman A.   +3 more
europepmc   +1 more source

Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia. [PDF]

RSC Med Chem
Holt-Martyn JP, Machado N, Coates JTT, Puliyadi R, Ashton T, Traynor E, Aslam S, Wise TK, Rodriguez-Berriguete G, Schofield CJ, Higgins GS.   +10 more
europepmc   +1 more source

A 35-Year-Old Woman With Recurrent Hypertriglyceridemia-Induced Pancreatitis in Pregnancy Managed With Fenofibrate and Plasmapheresis. [PDF]

Am J Case Rep
Wang J, Lu Z, Zhou C.
europepmc   +1 more source

Effects of PPARα, PPARγ, and dual PPARα/γ agonists on liver tissue and biochemical markers in NAFLD-induced Wistar rats. [PDF]

Res Pharm Sci
Khoshbakht E, Dinarvand N, Yaghooti H, Taheri B, Mohammadtaghvaei N.   +4 more
europepmc   +1 more source

Asymptomatic Pembrolizumab-Associated Hypertriglyceridemia. [PDF]

Cureus
Yeager LS, Zinner RG, Hao Z.
europepmc   +1 more source

PPARα activation alleviates lithocholic acid-induced liver injury by inhibiting pyroptosis. [PDF]

Liver Res
Liang HF, Mai CY, Li X, Tian JN, Su HG, Huang M, Fang JH, Wang HT, Yang X, Bi HC.   +9 more
europepmc   +1 more source

Tirzepatide in recurrent hypertriglyceridemia-mediated pancreatitis and type 2 diabetes: a case report. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Lechner B, Lechner K, Freibothe I, Vogt A.   +3 more
europepmc   +1 more source

Fenofibrate Mitigates Acute Lung Injury in a Rat Model of Feces-Induced Peritonitis. [PDF]

Int J Mol Sci
Akbaş A, Dasiran MF, Daghmoura H, Akbaş B, Aygun H, Serdaroglu A, Uyanikgil Y, Ercan G, Erbas O.   +8 more
europepmc   +1 more source

Pharmacological Targeting of Peroxisome 
Proliferator-activated Receptors for Prevention 
of Radiation-induced Cognitive Decline. [PDF]

Ann Neurosci
Ghanekar S, Raj JAT, Thiruselvan GK, Kulkarni R, Soni M, Chatterjee A, Patro I, Goda JS.   +7 more
europepmc   +1 more source